These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38934598)

  • 1. An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease.
    Kruk ME; Mehta S; Murray K; Higgins L; Do K; Johnson JE; Wagner R; Wendt CH; O'Connor JB; Harris JK; Laguna TA; Jagtap PD; Griffin TJ
    mSystems; 2024 Jul; 9(7):e0092923. PubMed ID: 38934598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel clinical metaproteomics workflow enables bioinformatic analysis of host-microbe dynamics in disease.
    Do K; Mehta S; Wagner R; Bhuming D; Rajczewski AT; Skubitz APN; Johnson JE; Griffin TJ; Jagtap PD
    mSphere; 2024 Jun; 9(6):e0079323. PubMed ID: 38780289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel clinical metaproteomics workflow enables bioinformatic analysis of host-microbe dynamics in disease.
    Do K; Mehta S; Wagner R; Bhuming D; Rajczewski AT; Skubitz APN; Johnson JE; Griffin TJ; Jagtap PD
    bioRxiv; 2023 Dec; ():. PubMed ID: 38045370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
    Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
    PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis.
    Taylor SL; Leong LEX; Ivey KL; Wesselingh S; Grimwood K; Wainwright CE; Rogers GB;
    J Cyst Fibros; 2020 Nov; 19(6):923-930. PubMed ID: 32199729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.
    Pittman JE; Wylie KM; Akers K; Storch GA; Hatch J; Quante J; Frayman KB; Clarke N; Davis M; Stick SM; Hall GL; Montgomery G; Ranganathan S; Davis SD; Ferkol TW;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1548-1555. PubMed ID: 28708417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients.
    McMorran BJ; Patat SA; Carlin JB; Grimwood K; Jones A; Armstrong DS; Galati JC; Cooper PJ; Byrnes CA; Francis PW; Robertson CF; Hume DA; Borchers CH; Wainwright CE; Wainwright BJ
    Clin Chem; 2007 Oct; 53(10):1782-91. PubMed ID: 17702859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis.
    O'Connor JB; Mottlowitz M; Kruk ME; Mickelson A; Wagner BD; Harris JK; Wendt CH; Laguna TA
    Front Cell Infect Microbiol; 2022; 12():805170. PubMed ID: 35360097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.
    Ronchetti K; Tame JD; Paisey C; Thia LP; Doull I; Howe R; Mahenthiralingam E; Forton JT
    Lancet Respir Med; 2018 Jun; 6(6):461-471. PubMed ID: 29778403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children.
    Muhlebach MS; Zorn BT; Esther CR; Hatch JE; Murray CP; Turkovic L; Ranganathan SC; Boucher RC; Stick SM; Wolfgang MC
    PLoS Pathog; 2018 Jan; 14(1):e1006798. PubMed ID: 29346420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture-Independent Analysis of Pediatric Bronchoalveolar Lavage Specimens.
    Zachariah P; Ryan C; Nadimpalli S; Coscia G; Kolb M; Smith H; Foca M; Saiman L; Planet PJ
    Ann Am Thorac Soc; 2018 Sep; 15(9):1047-1056. PubMed ID: 29877714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
    O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
    PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
    Dosanjh AK; Elashoff D; Robbins RC
    J Interferon Cytokine Res; 1998 Oct; 18(10):851-4. PubMed ID: 9809620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives.
    Hardouin P; Chiron R; Marchandin H; Armengaud J; Grenga L
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J; McNally P; John B; DeSantis T; Linnane B; Murphy P;
    PLoS One; 2014; 9(12):e109798. PubMed ID: 25526264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
    Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
    Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
    Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K
    Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection.
    Cribbs SK; Uppal K; Li S; Jones DP; Huang L; Tipton L; Fitch A; Greenblatt RM; Kingsley L; Guidot DM; Ghedin E; Morris A
    Microbiome; 2016 Jan; 4():3. PubMed ID: 26792212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three clinically distinct chronic pediatric airway infections share a common core microbiota.
    van der Gast CJ; Cuthbertson L; Rogers GB; Pope C; Marsh RL; Redding GJ; Bruce KD; Chang AB; Hoffman LR
    Ann Am Thorac Soc; 2014 Sep; 11(7):1039-48. PubMed ID: 24597615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.